Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Evaluate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01496937
What this trial is testing

First-in-Human Exploratory Single Ascending Dose of GLPG0974

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 32
Early research (Phase 1)Looking for participantsNCT05945537
What this trial is testing

INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis
Inipharm Australia Pty Ltd 168
Testing effectiveness (Phase 2)Study completedNCT04328077
What this trial is testing

LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 101
Testing effectiveness (Phase 2)UnknownNCT02353039
What this trial is testing

Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis

Who this might be right for
Gastritis
Green Cross Corporation 200
Testing effectiveness (Phase 2)Ended earlyNCT04958031
What this trial is testing

A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy

Who this might be right for
Apathy in Dementia
AbbVie 41
Post-approval studies (Phase 4)Ended earlyNCT00381095
What this trial is testing

Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer

Who this might be right for
Bone NeoplasmsPain, IntractableCancer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07199777
What this trial is testing

A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patients

Who this might be right for
Diabetic Macular EdemaDME
SciNeuro 60
Testing effectiveness (Phase 2)Study completedNCT05010577
What this trial is testing

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Who this might be right for
Chronic Pseudomonas Aeruginosa InfectionCystic Fibrosis
BiomX, Inc. 43
Not applicableEnded earlyNCT02649075
What this trial is testing

To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease

Who this might be right for
Crohn's Disease
Entera Health, Inc 7
Testing effectiveness (Phase 2)Study completedNCT01010581
What this trial is testing

SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
4SC AG 266
Testing effectiveness (Phase 2)Study completedNCT01113619
What this trial is testing

Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance

Who this might be right for
Lactose Intolerance
Ritter Pharmaceuticals, Inc. 61
Not applicableStudy completedNCT05902819
What this trial is testing

Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories

Who this might be right for
Post-traumatic Stress DisorderCocaine Use Disorder
Psychiatric University Hospital, Zurich 138
Large-scale testing (Phase 3)Looking for participantsNCT07669519
What this trial is testing

Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients Undergoing First-Line Chemotherapy

Who this might be right for
FatigueColon Cancer
Natureceuticals Sdn Bhd 180
Large-scale testing (Phase 3)Study completedNCT01917019
What this trial is testing

A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Remittent ProgressiveMultiple Sclerosis, Primary ProgressiveRelapsing-Remitting Multiple Sclerosis+2 more
Biogen 101
Testing effectiveness (Phase 2)UnknownNCT04885972
What this trial is testing

Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis

Who this might be right for
Osteoarthritis, KneeKnee OsteoarthritisKnee Pain Chronic
Sorrento Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Study completedNCT05378360
What this trial is testing

DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities

Who this might be right for
Rash Acneiform
Daewoong Pharmaceutical Co. LTD. 96
Large-scale testing (Phase 3)Study completedNCT04409262
What this trial is testing

Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Hoffmann-La Roche 649
Testing effectiveness (Phase 2)Ended earlyNCT03919162
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD

Who this might be right for
Alzheimer Disease
Vivoryon Therapeutics N.V. 112
Testing effectiveness (Phase 2)Study completedNCT03482713
What this trial is testing

Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033)

Who this might be right for
Chronic Cough
Merck Sharp & Dohme LLC 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714213
What this trial is testing

Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)

Who this might be right for
Post-acute Infectious Syndrome (PAIS)Post-COVID-19 Condition (PCC or Long COVID)
Christiana Franke 138
Next Page